MedTech Spectrum

Article Name Medical Devices

Easydrip™ Plus Lands in Central Asia: Making Daily Insulin Safer, Gentler, More Affordable

Sandstone’s Easydrip™ Plus launches in Uzbekistan with premium features and everyday pricing; Ming Shen outlines the education-first approach and regional expansion plans.

03rd September, 2025

Phraxis Announces First-Ever Commercial Case of EndoForce Anastomotic Connector

The technology is compatible with all PTFE grafts and was studied extensively in the company's pivotal clinical trial

02nd September, 2025

Sandstone Easydrip Plus Pen Needles Debut in Uzbekistan

Easydrip Plus uses a large platform hub for a steadier grip and control

02nd September, 2025

Modern Dental Group Reports 34.7% Surge in 1H2025 Net Profit

Continuous Enhancement of Operational Efficiency and Productivity under Accelerated Digitalisation in Dentistry

01st September, 2025

Abbott’s Navitor™ Wins CE Mark Expansion, Offering Minimally Invasive Valve Replacement to Low- and Intermediate-Risk Patients in Europe

Backed by VANTAGE trial data unveiled at ESC Congress 2025 and published in JACC: Cardiovascular Interventions, Navitor now covers all surgical risk categories—while new ESC/EACTS guidelines also strengthen support for MitraClip™ and TriClip™ in mitral and tricuspid valve disease management.

01st September, 2025

Proton Centre in South Korea selects RayStation and RayCare

This technique allows for highly precise radiation delivery while minimising exposure to surrounding healthy tissue

28th August, 2025

SimBioSys and Ricoh 3D for Healthcare announce strategic alliance expanding access to TumorSight Viz for breast cancer surgery

Commercial partnership expected to accelerate adoption of SimBioSys' AI-powered surgical visualisation platform following recent FDA clearance of TumorSight Viz 1.3

28th August, 2025

Neusoft Medical Systems Launches China's First Photon-Counting CT with NMPA Approval

Photon-counting CT (PCCT) is considered a breakthrough in next-generation imaging

28th August, 2025

Neurolief Prepares for Launch of ProlivRx System for Major Depressive Disorder with Strategic Investment from BrainsWay

The partnership reflects an exciting strategic alignment between the two companies

22nd August, 2025

Orange Biomed Lands on Fortune Korea's Top 40 with Portable Diabetes Test

The OBM rapid A1C is the first portable device to measure glycated haemoglobin (A1C) using microfluidic technology

22nd August, 2025

MellingMedical Partners with Sightpath Medical to Enhance Ophthalmic Surgical Care

Advanced mobile surgical solutions to improve access to eye care for veterans, active duty and DoD personnel

21st August, 2025

Chemo Mouthpiece Medical Device Significantly Reduces Oral Pain

Use of the Chemo Mouthpiece resulted in a 46 per cent reduction in patient-reported oral pain symptoms compared to the control group

21st August, 2025

Ategenos Emerges from Stealth to Debut First-Ever SmartPatch Platform

Introducing the first scalable solution enabling real-time interventions for medication non-adherence

20th August, 2025

Triojection from SpinaFX Granted Breakthrough Device Designation by U.S. FDA

This milestone acknowledges Triojection's potential to offer a highly effective, more accessible, and safer treatment for patients suffering from contained lumbar disc herniations

18th August, 2025

Protera Health Integrates with Epic to Deliver Seamless Digital MSK Care for Health Plans and Health Systems

Integration aims to enhance care coordination, transparency, and outcomes for musculoskeletal patients through EpicCare Link.

14th August, 2025

DeepSight™ Technology Receives First FDA 510(k) Clearance for NeedleVue™ LC1 Ultrasound System

Bringing Clarity and Confidence to Ultrasound-Guided Interventional Procedures

14th August, 2025

OncoBeta reports 12-Month Results from International Phase IV Study for Non-Melanoma Skin Cancer

Quarterly rehab program now welcomes Parkinson’s patients, offering intensive therapy with NeuFit’s NEUBIE device.

14th August, 2025

Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision

Kangji Medical Holdings Limited and Knight Bidco Limited today jointly announced the pre-conditional proposal for the privatisation of Kangji Medical Holdings Limited by way of a scheme of arrangement (the “Proposal”). Proposed privatisation of Kangji Medical Holdings Limited The Cancellation Price of HK$9.25 per share represents a 21.7% premium over the closing price on 30 June, 2025, being the Undisturbed Date, a 47.3% premium over the 360-trading day average closing price up to and including the Undisturbed Date, and exceeds the highest closing price as quoted on the Stock Exchange since 2022 The proposed privatisation will be effected by way of a scheme of arrangement; the Offeror Concert Parties collectively hold 74.75% shares in the Company; an Irrevocable Undertaking has been received from one institutional shareholder to vote in favour of the Proposal The Proposal presents shareholders with certainty over their ability to monetise their interests in Kangji Medical Holdings Limited, following a period of sustained pressure on trading prices and limited liquidity

13th August, 2025